References
Actor, J. K., Hwang, S.-A., & Kruzel, M. L. (2009). Lactoferrin as a natural immune modulator. Current Pharmaceutical Design ,15 (17), 1956–1973. https://doi.org/10.2174/138161209788453202
Andersen, J. H., Jenssen, H., Sandvik, K., & Gutteberg, T. J. (2004). Anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface. Journal of Medical Virology . https://doi.org/10.1002/jmv.20171
Baveye, S., Elass, E., Mazurier, J., Spik, G., & Legrand, D. (1999). Lactoferrin: A multifunctional glycoprotein involved in the modulation of the inflammatory process. Clinical Chemistry and Laboratory Medicine . https://doi.org/10.1515/CCLM.1999.049
Behrens, E. M., & Koretzky, G. A. (2017). Review: Cytokine Storm Syndrome: Looking Toward the Precision Medicine Era. Arthritis & Rheumatology (Hoboken, N.J.) , 69 (6), 1135–1143. https://doi.org/10.1002/art.40071
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M., & Sibbald, W. J. (1992). Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.Chest , 101 (6), 1644–1655. https://doi.org/10.1378/chest.101.6.1644
Bruni, N., Capucchio, M. T., Biasibetti, E., Pessione, E., Cirrincione, S., Giraudo, L., Corona, A., & Dosio, F. (2016). Antimicrobial activity of lactoferrin-related peptides and applications in human and veterinary medicine. Molecules (Basel, Switzerland) , 21 (6). https://doi.org/10.3390/molecules21060752
Burckhardt, C. J., & Greber, U. F. (2009). Virus movements on the plasma membrane support infection and transmission between cells. InPLoS Pathogens . https://doi.org/10.1371/journal.ppat.1000621
Chang, R., Sun ,WZ. Lactoferrin may reduce the incidence and attenuate the severity of COVID-19 in infants and children . Preprint at:https://doi.org/10.22541/au.158586333.32247750(2020)
Chen, Y., Liu, Q., & Guo, D. (2020). Emerging coronaviruses: Genome structure, replication, and pathogenesis. In Journal of Medical Virology . https://doi.org/10.1002/jmv.25681
de Haan, C. A. M., Li, Z., te Lintelo, E., Bosch, B. J., Haijema, B. J., & Rottier, P. J. M. (2005). Murine coronavirus with an extended host range uses heparan sulfate as an entry receptor. Journal of Virology . https://doi.org/10.1128/jvi.79.22.14451-14456.2005
Egashira, M., Takayanagi, T., Moriuchi, M., & Moriuchi, H. (2007). Does daily intake of bovine lactoferrin-containing products ameliorate rotaviral gastroenteritis? Acta Paediatrica, International Journal of Paediatrics . https://doi.org/10.1111/j.1651-2227.2007.00393.x
Fung, S.-Y., Yuen, K.-S., Ye, Z.-W., Chan, C.-P., & Jin, D.-Y. (2020). A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses.Emerging Microbes & Infections , 9 (1), 558–570. https://doi.org/10.1080/22221751.2020.1736644
Guntupalli, K., Dean, N., Morris, P. E., Bandi, V., Margolis, B., Rivers, E., Levy, M., Lodato, R. F., Ismail, P. M., Reese, A., Schaumberg, J. P., Malik, R., & Dellinger, R. P. (2013). A Phase 2 Randomized, Double-Blind, Placebo–Controlled Study of the Safety and Efficacy of Talactoferrin in Patients With Severe Sepsis*.Critical Care Medicine , 41 (3), 706–716. https://doi.org/10.1097/CCM.0b013e3182741551
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., Müller, M. A., Drosten, C., & Pöhlmann, S. (2020). SARS-CoV-2 Cell Entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell . https://doi.org/10.1016/j.cell.2020.02.052
Hong, H., Wang, Y., Chung, H.-T., & Chen, C.-J. (2020). Clinical characteristics of novel coronavirus disease 2019 (COVID-19) in newborns, infants and children. Pediatrics and Neonatology . https://doi.org/10.1016/j.pedneo.2020.03.001
Ishikado, A., Imanaka, H., Takeuchi, T., Harada, E., & Makino, T. (2005). Liposomalization of lactoferrin enhanced it’s anti-inflammatory effects via oral administration. Biological & Pharmaceutical Bulletin , 28 (9), 1717–1721. https://doi.org/10.1248/bpb.28.1717
Johanson, B., Virtanen, A. I., Tweit, R. C., & Dodson, R. M. (1960). Isolation of an iron-containing red protein from human milk. Acta Chemica Scandinavica . https://doi.org/10.3891/acta.chem.scand.14-0510
Jolles, J., Mazurier, J., Schoentgen, F., Legrand, D., Spik, G., Montreuil, J., & Jolles, P. (1984). Human lactotransferrin : amino acid sequence and structural comparisons with other transferrins.European Journal of Biochemistry .
Kaito, M., Iwasa, M., Fujita, N., Kobayashi, Y., Kojima, Y., Ikoma, J., Imoto, I., Adachi, Y., Hamano, H., & Yamauchi, K. (2007). Effect of lactoferrin in patients with chronic hepatitis C: combination therapy with interferon and ribavirin. Journal of Gastroenterology and Hepatology , 22 (11), 1894–1897. https://doi.org/10.1111/j.1440-1746.2007.04858.x
Kruzel, M L, Harari, Y., Chen, C. Y., & Castro, G. A. (2000). Lactoferrin protects gut mucosal integrity during endotoxemia induced by lipopolysaccharide in mice. Inflammation , 24 (1), 33–44. https://doi.org/10.1023/a:1006935908960
Kruzel, Marian L, Actor, J. K., Radak, Z., Bacsi, A., Saavedra-Molina, A., & Boldogh, I. (2010). Lactoferrin decreases LPS-induced mitochondrial dysfunction in cultured cells and in animal endotoxemia model. Innate Immunity , 16 (2), 67–79. https://doi.org/10.1177/1753425909105317
Kruzel, Marian L, Zimecki, M., & Actor, J. K. (2017). Lactoferrin in a context of inflammation-induced pathology. Frontiers in Immunology , 8 , 1438. https://doi.org/10.3389/fimmu.2017.01438
Kuchler, H., Cookson, C., & Neville, S. (2020, March 6). The $2bn race to find a vaccine. Financial Times , 7. https://www.ft.com/content/e0ecc6b6-5d43-11ea-b0ab-339c2307bcd4
Lang, J., Yang, N., Deng, J., Liu, K., Yang, P., Zhang, G., & Jiang, C. (2011). Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans. PloS One , 6 (8), e23710. https://doi.org/10.1371/journal.pone.0023710
Legrand, D., Elass, E., Carpentier, M., & Mazurier, J. (2006). Interactions of lactoferrin with cells involved in immune function.Biochemistry and Cell Biology . https://doi.org/10.1139/O06-045
Levay, P. F., & Viljoen, M. (1995). Lactoferrin: a general review.Haematologica , 80 (3), 252–267. http://www.ncbi.nlm.nih.gov/pubmed/7672721
Lu, L., Hangoc, G., Oliff, A., Chen, L. T., Shen, R. N., & Broxmeyer, H. E. (1987). Protective influence of lactoferrin on mice infected with the polycythemia-inducing strain of Friend virus complex. Cancer Research , 47 (15), 4184–4188. http://www.ncbi.nlm.nih.gov/pubmed/3038309
Marchetti, M., Superti, F., Ammendolia, M. G., Rossi, P., Valenti, P., & Seganti, L. (1999). Inhibition of poliovirus type 1 infection by iron-, manganese- and zinc-saturated lactoferrin. Medical Microbiology and Immunology , 187 (4), 199–204. https://doi.org/10.1007/s004300050093
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., Manson, J. J., & HLH Across Speciality Collaboration, U. (2020). COVID-19: consider cytokine storm syndromes and immunosuppression.Lancet (London, England) . https://doi.org/10.1016/S0140-6736(20)30628-0
Milewska, A., Zarebski, M., Nowak, P., Stozek, K., Potempa, J., & Pyrc, K. (2014). Human coronavirus NL63 utilizes heparan sulfate proteoglycans for attachment to target cells. Journal of Virology ,88 (22), 13221–13230. https://doi.org/10.1128/JVI.02078-14
Ng, T. B., Cheung, R. C. F., Wong, J. H., Wang, Y., Ip, D. T. M., Wan, D. C. C., & Xia, J. (2015). Antiviral activities of whey proteins.Applied Microbiology and Biotechnology . https://doi.org/10.1007/s00253-015-6818-4
Nozaki, A., Ikeda, M., Naganuma, A., Nakamura, T., Inudoh, M., Tanaka, K., & Kato, N. (2003). Identification of a lactoferrin-derived peptide possessing binding activity to hepatitis C virus E2 envelope protein.The Journal of Biological Chemistry , 278 (12), 10162–10173. https://doi.org/10.1074/jbc.M207879200
Oda, H., Nakano, M., Wakabayasi, H., Koji, Y., Toida, T., Iwatsuki, K., & Matsumoto, T. (2012). Questionnaire survey on the subjective effects of a lactoferrin supplement. Japanese Journal of Complementary and Alternative Medicine , 9 (2), 121–128. https://doi.org/10.1625/jcam.9.121
Puddu, P., Borghi, P., Gessani, S., Valenti, P., Belardelli, F., & Seganti, L. (1998). Antiviral effect of bovine lactoferrin saturated with metal ions on early steps of human immunodeficiency virus type 1 infection. The International Journal of Biochemistry & Cell Biology , 30 (9), 1055–1062. https://doi.org/10.1016/s1357-2725(98)00066-1
Razak, A., & Hussain, A. (2019). Lactoferrin supplementation to prevent late-onset sepsis in preterm infants: A meta-analysis. American Journal of Perinatology . https://doi.org/10.1055/s-0039-1696676
Rosa, L., Cutone, A., Lepanto, M. S., Paesano, R., & Valenti, P. (2017). Lactoferrin: A natural glycoprotein involved in iron and inflammatory homeostasis. In International Journal of Molecular Sciences . https://doi.org/10.3390/ijms18091985
Sapp, M., & Bienkowska-Haba, M. (2009). Viral entry mechanisms: Human papillomavirus and a long journey from extracellular matrix to the nucleus. In FEBS Journal . https://doi.org/10.1111/j.1742-4658.2009.07400.x
Siqueiros-Cendón, T., Arévalo-Gallegos, S., Iglesias-Figueroa, B. F., García-Montoya, I. A., Salazar-Martínez, J., & Rascón-Cruz, Q. (2014). Immunomodulatory effects of lactoferrin. Acta Pharmacologica Sinica , 35 (5), 557–566. https://doi.org/10.1038/aps.2013.200
Soerensen, M, S. S. (1939). The protein in whey. C R Trav Lab Carlsberg , 23 , 55–00.
Spear, P. G. (2004). Herpes simplex virus: Receptors and ligands for cell entry. In Cellular Microbiology . https://doi.org/10.1111/j.1462-5822.2004.00389.x
Vincent, J. L., Marshall, J. C., Dellinger, R. P., Simonson, S. G., Guntupalli, K., Levy, M. M., Singer, M., & Malik, R. (2015). Talactoferrin in severe sepsis: results from the phase II/III Oral talactoferrin in severe sepsis trial. Critical Care Medicine . https://doi.org/10.1097/CCM.0000000000001090
Vitetta, L., Coulson, S., Beck, S. L., Gramotnev, H., Du, S., & Lewis, S. (2013). The clinical efficacy of a bovine lactoferrin/whey protein Ig-rich fraction (Lf/IgF) for the common cold: A double blind randomized study. Complementary Therapies in Medicine . https://doi.org/10.1016/j.ctim.2012.12.006
Wakabayashi, H., Oda, H., Yamauchi, K., & Abe, F. (2014). Lactoferrin for prevention of common viral infections. In Journal of Infection and Chemotherapy . https://doi.org/10.1016/j.jiac.2014.08.003
Wei, M., Yuan, J., Liu, Y., Fu, T., Yu, X., & Zhang, Z.-J. (2020). Novel coronavirus infection in hospitalized infants under 1 year of age in China. JAMA . https://doi.org/10.1001/jama.2020.2131
Zhang, L., & Liu, Y. (2020). Potential interventions for novel coronavirus in China: A systematic review. Journal of Medical Virology , 92 (5), 479–490. https://doi.org/10.1002/jmv.25707
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., Niu, P., Zhan, F., Ma, X., Wang, D., Xu, W., Wu, G., Gao, G. F., & Tan, W. (2020). A novel coronavirus from patients with pneumonia in China, 2019. New England Journal of Medicine ,382 (8), 727–733. https://doi.org/10.1056/NEJMoa2001017
Zimecki, M., Właszczyk, A., Zagulski, T., & Kübler, A. (1998). Lactoferrin lowers serum interleukin 6 and tumor necrosis factor alpha levels in mice subjected to surgery. Archivum Immunologiae et Therapiae Experimentalis , 46 (2), 97–104. http://www.ncbi.nlm.nih.gov/pubmed/9613707